Stay ahead of emerging resistance

the trusted way.

For more than 30 years, MicroScan
Systems have been exclusively focused
on ID/AST testing, offering unmatched
experience, expertise, and technical
support to help guide physicians and
improve patient care.
MicroScan Dried Overnight Gram
Negative Panels from Siemens now
continue a tradition of quality and
innovation. They are designed to help
keep your laboratory staff at the
forefront of identification and
susceptibility testing and are compatible
with all MicroScan instruments.
Provide clinically relevant
identification from an extensive
database of gram-negative
microorganisms

Versatility for your unique

testing needs
Experience flexibility and choice
through dynamic MicroScan menu
options designed to streamline testing
and help boost your efficiency.
Manage changing formulary needs
with a broad antimicrobic menu and
more than 95 MicroScan panel
choices (available globally)
Select ID-only, AST-only, and
ID/AST combination panels for
workflow flexibility
Utilize a one-panel format for all
Siemens microbiology instruments
for simplified testing procedures
and streamlined workflow

Confirm or screen for extendedspectrum beta-lactamases (ESL)

with routine panels
Perform and interpret
tests both manually or on
MicroScan instrumentation

First-time accuracy
The MicroScan system uses a growth-based, non-ID-dependent direct
testing method, which allows for better detection of emerging resistance.
The system does not rely on historical data: It provides a real-time
advantage for accuracy and uses direct MIC* technology to detect
emerging and low-level resistance. This means fewer confirmatory
tests are needed, providing you with accurate results the first time.
This functionality aligns with most CLSI guidelines to improve detection
of resistance mechanisms without additional confirmation tests.

Siemens Healthcare Diagnostics, a global leader

in clinical diagnostics, provides healthcare
professionals in hospital, reference, and physician
office laboratories and point-of-care settings with
the vital information required to accurately
diagnose, treat, and monitor patients. Our
innovative portfolio of performance-driven
solutions and personalized customer care
combine to streamline workflow, enhance
operational efficiency, and support improved
patient outcomes.
MicroScan is a trademark of Siemens Healthcare
Diagnostics Inc.
Not available for sale in the U.S.
Product availability may vary from country to
country and is subject to varying regulatory
requirements. Please contact your local
representative for availability.
Order No. A91DX-MM-131347-GC1-4A00
11-2013 | All rights reserved
2013 Siemens Healthcare Diagnostics Inc.

Aligns
with most
EUCAST
guidelines

Global Division
Siemens Healthcare Diagnostics Inc.
511 Benedict Avenue
Tarrytown, NY 10591-5005
USA
www.siemens.com/diagnostics

www.siemens.com/microbiology
Global Siemens Headquarters
Siemens AG
Wittelsbacherplatz 2
80333 Muenchen
Germany

Global Siemens Healthcare

Headquarters Siemens AG
Healthcare Sector
Henkestrasse 127
91052 Erlangen
Telephone: + 49 9131 84-0
Germany
www.siemens.com/healthcare

Your First Choice in

Resistance Detection
MicroScan Gram Negative
Conventional Panels

*Minimum inhibitory concentration

www.siemens.com/diagnostics

Answers for life.

Panel Definitions

Panel Name

Neg
Combo 53

Neg
Combo 58

Neg EN
Combo 70

Neg NF
Combo 71

Neg BP
Combo 45

Neg BP
Combo 46

Neg BP
Combo 49

Neg/Urine
Combo 56

Neg/Urine
Combo 57

Neg/Urine
Combo 59

Neg/Urine
Combo 69

Neg MIC 39

Neg MIC 40

Neg MIC 44

SMN

10371524

10479100

10713832

10713833

10479095

10479104

10713834

10479092

10479098

10479101

10713831

10479097

10479105

10713830

Legacy Catalog Number

B1016 142

B1016 158

B1016 177

B1016178

B1016 153

B1016162

B1016 179

B1016 150

B1016 156

B1016 159

B1016 176

B1016 155

B1016 163

B1016 175

Languages

E, ES, GR, NO,

PL, PT, TR

E, ES, GR,
PL, PT

E, FR, NO

E, ES, GR, PL, PT

DE, E, ES, FR, GR,

IT, PL, PT, TR

E, FR, NO

Abbr.

Antimicrobic Agent

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

Abbr.

Ak
Amx
Aug
Am
A/S
Azt
Cfz
Cpe
Cfe
Cft
Cfx
Cpd
Caz
Cax
Crm
Cf
C
Cp
Cl
Dor
Etp

Amikacin
Amoxicillin
Amoxicillin/K Clavulanate
Ampicillin
Ampicillin/Sulbactam
Aztreonam
Cefazolin
Cefepime
Cefixime
Cefotaxime
Cefoxitin
Cefpodoxime
Ceftazidime
Ceftriaxone
Cefuroxime
Cephalothin
Chloramphenicol
Ciprofloxacin
Colistin
Doripenem
Ertapenem
ESL Confirmation Cefotaxime/
K Clavulanate
ESL Confirmation Ceftazidime/
K Clavulanate
Fosfomycin
Gentamicin
Imipenem
Levofloxacin
Mecillinam
Meropenem
Minocycline
Moxifloxacin
Nalidixic Acid
Nitrofurantoin
Norfloxacin
Ofloxacin
Piperacillin
Piperacillin/Tazobactam
Tetracycline
Ticarcillin
Ticarcillin/K Clavulanate
Tigecycline
Tobramycin
Trimethoprim
Trimethoprim/Sulfamethoxazole

8 32

8/4 16/8
8 16

1, 8 16
8 16
1, 8 16

1 32
8 16

1, 4 16

4 16
8 16

0.5 2

0.5 4

8 32

4/2 16/8
1 16

1 16

1 32

0.5 2
2 4

8 32

8/4 16/8
8 16

1, 4 16

1 16
8 16

1 8

8 16
8 16

0.5 2

0.5 1

8 32

8/4 16/8
1 16

1, 4 16

8 32

1 16

0.5 2
2 4
1 4

816

2/18/4
28

1, 48

12, 16
8
1
1, 48

48

8
0.51
24

0.51

1632

816
8/416/8

816

12, 832
8

1, 416

416

12
24

0.51

816

2/18/4
28

1, 816

1, 48

12, 16
8

1, 48

48
8

0.51
24

0.51

8 16
4 8
4/2 8/4

1, 8 16

1, 8
1 2
1 2, 16
8, 32

1, 4 8

8
8, 32

0.5 2
2 4

0.5 1

8/4 16/8
8 16

8 16
1, 8 16

1 32
8 16

1 16

4 16
8 16

0.5 2

0.5 1

8 16

4/2 16/8
8 16

1 16
8 16

1 16

8 16

0.5 2

0.5 1

4 16
1 8
2/1 8/4

1 16

0.5 8
1 2
0.5 2, 16
2 8, 32

0.5 8

8 32

0.25 2
2
1, 4
0.5 1

8 16

2/1 8/4
0.5 8
1/0.5 8/4
1, 8 16

0.5 8

0.5 2, 16
8 16
0.5 1
0.5 8
0.5 2
1 8

8
0.5 1
2
1 4
0.5 1

8 32

8/4 16/8
8 16
8/4 16/8
1, 4 16

1 16

1 32
8 16

1 16

4 16
8 16
8 16
0.5 2
2 4
1 4
0.5 1

Ak
Amx
Aug
Am
A/S
Azt
Cfz
Cpe
Cfe
Cft
Cfx
Cpd
Caz
Cax
Crm
Cf
C
Cp
Cl
Dor
Etp

0.5/4 1/4, 4/4

0.5/4 1/4, 4/4

816

8/416/8
816

1, 8
816
1, 8

132
816

1, 816

48

0.51

0.51
0.5/4,
4/48/4

0.5/4, 4/4

0.5/4, 4/4

0.5/4, 4/4

0.5/4, 4/4

0.5/4 4/4

0.5/4 4/4

0.5/4, 4/4

0.5/4, 4/4

0.5/4 4/4

Cft/CA

0.25/4, 2/4

0.25/4, 2/4

0.25/4, 2/4

0.25/4, 2/4

0.25/4, 2/4

0.25/4, 2/4

0.25/4, 2/4

0.25/4, 2/4

16 64
1 8
1 8
1 4

1 8
4 8

8 64

8 32

0.5 2
2 8

2/38

2 8
1 8
1 4

1 8

8 16, 64

1 2
2 8

2/38 4/76

2 8
1 8
1 4

1 8
4 8

8 16, 64
8 16, 64

16, 64

1 2
2 8

2/38 4/76

32
2 4
2 8
1 2

2 8

32 64
0.5 1

8 16
8 16
4 8

1 2
2 4

2/38 4/76

32
2 4
2 8
1 2

2, 8

0.5 1

64
0.5 1

4 16
4 16
4 8

1 2
2 4
8
2/38 4/76

32 64
4 8
1 8
2 4

1 8

0.5 1
16
32 64

16,64
16,64
4 8

1 2
4 8

2/38 4/76

32
2 4
2 8
1 2
8
2 8

0.5 1
16
64

8 16
8 16

8 16
1 2
2 4
8
2/38 4/76

32
2 4
2 8

8 16
64
0.5 1
0.5 1

8 16
4 8
8 16
8 16
1 2
2 4

2/38 4/76

0.25/4
0.5/4, 2/4
32 64
2 8
1 8
1 4

1 8

16
32 64
0.5 1

8 16, 64

2 8

2/38 4/76

0.25/4, 2/4

2 8
1 8

16

8 16, 64

1 2
2 8

2/38

0.25/4
0.5/4,2/4
16 64
2 8
1 8

16
32 64
0.5 1

8 16, 64

2 8

2/38 4/76

32
1 4
0.5 8

8 16
64
0.5 1
0.5 4
8 16, 64
4 16, 64

8 64
8 64
1 4
1 4

2/38 4/76

32
2 4
1 8
1 2

0.5 8

0.5 1

64
0.5 1
0.5 1
4 16
4 16
4 8

0.25 2
2 4
8
2/38 4/76

0.25/4
0.5/4, 2/4
32 64
2 8
1 8
1 4

1 8
4 8

16
32 64
0.5 1

8 16, 64
8 16, 64
4 8

1 2
2 8

2/38 4/76

22

18

21

20

27

30

27

31

31

22

22

31

35

33

Cft/CA
Caz/CA
Fos
Gm
Imp
Lvx
Mec
Mer
Min
Mxf
NA
Fd
Nxn
Ofl
Pi
P/T
Te
Ti
Tim
Tgc
To
T
T/S

Total Antimicrobics/Panel

DE, E, ES, FR, GR,

DE, E, ES, FR,
IT, PL, PT, TR
GR, IT, PL, PT, TR

DE, E, GR, IT,

NO, PL

DE, E, FR, GR,

DE, E, ES, FR,
E, GR, NO, PL
IT, NO, PL
GR, IT, PL, PT, TR

Neg Combo: Provides gram-negative

identification and susceptibility results
on one panel. Drug selection provides
both Enterobacteriaceae and NonEnterobacteriaceae coverage, as well
as systemic reporting.

DE, E, FR, GR, DE, E, ES, FR, GR,

IT, NO, PL, PT IT, KO, PL, PT, TR

Caz/CA
Fos
Gm
Imp
Lvx
Mec
Mer
Min
Mxf
NA
Fd
Nxn
Ofl
Pi
P/T
Te
Ti
Tim
Tgc
To
T
T/S

Neg EN Combo (Neg Entero Combo

Panel Type 70): Provides gram-negative
identification and susceptibility results
on one panel. Drug selection provides
Enterobacteriaceae coverage, as well as
urine and systemic reporting.
Neg NF Combo (Neg Non-Entero
Combo Panel Type 71): Provides
gram-negative identification and
susceptibility results on one panel.
Drug selection provides NonEnterobacteriaceae coverage, as well
as urine and systemic reporting.
Neg BP (Breakpoint) Combo:
Provides gram-negative identification
and susceptibility results on one
Enterobacteriaceae and NonEnterobacteriaceae coverage, as
well as urine and systemic reporting.
Panel contains shorter dilutions
around the breakpoints, allowing
for a broader drug menu.
Neg/Urine Combo: Provides gramnegative identification and susceptibility
results on one panel. Drug selection
provides both Enterobacteriaceae and
Non-Enterobacteriaceae coverage,
as well as urine and systemic reporting
Neg MIC panels: Provides gram-negative
susceptibility results only and longer
dilution schemes for better detection
of emerging resistance. Drug selection
provides both Enterobacteriaceae and
Non-Enterobacteriaceae coverage,
as well as urine and systemic reporting.
Not for sale in the U.S., China, or Japan

Legend:
DE German
E English
ES Spanish
FR French
GR Greek
IT Italian
NO Norwegian
PL Polish
PT Portuguese
TR Turkish